Clinical Trials in Michigan

Showing 9041-9060 of 16,154 trials

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03489369

This is the first study to test Sym022 in humans. The primary purpose of this study is to see if Sym022 is safe and tolerable for patients with locally advanced/unresectable or metastatic solid tumor malignancies or lymphomas that are refractory to available therapy or for which no standard therapy is available.

Metastatic CancerSolid TumorLymphoma

Symphogen A/S15 participantsStarted May 2018

Grand Rapids, Michigan, United States • Houston, Texas, United States • Toronto, Ontario, Canada

COMPLETEDPhase 483 miles

PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

NCT01766440

The purpose of this study is to determine if the calcitriol absorption in pediatric subjects is comparable to that in adults and adolescents, with no significant impact on calcium/phosphorus metabolism.

Plaque Psoriasis

Galderma R&D18 participantsStarted Mar 2013

San Diego, California, United States • Indianapolis, Indiana, United States • Ann Arbor, Michigan, United States +5 more locations

COMPLETEDPhase 383 miles

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

NCT00277498

To demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure measurements at 8 AM, 10 AM, 4 PM at weeks 2, 6 and 12.

Open Angle GlaucomaOcular Hypertension

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.528 participantsStarted Dec 2005

Birmingham, Alabama, United States • Flagstaff, Arizona, United States • Artesia, California, United States +61 more locations

Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Find Trials by Condition in Michigan

Phase 3 Papulopustular Rosacea Study

Epiduo Pediatric Acne Study

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Botulinum Toxin A to Treat Arm Tremor

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris